ImmunoCellular Therapeutics to use BioWa's Potelligent technology for anticancer antibodies June 6, 2011
AVEO and Centocor Ortho Biotech enter license agreement for antibodies targeting MSP receptor June 3, 2011
Bristol-Myers Squibb and Roche enter agreement to evaluate ipilimumab/vemurafenib combination June 3, 2011
RSS